The successful scale-up of direct-acting antiviral hepatitis C treatments will benefit from concerted investments in implementation science
Crossref DOI link: https://doi.org/10.17269/s41997-018-0164-0
Published Online: 2019-01-08
Published Print: 2019-06-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Knight, Rod http://orcid.org/0000-0002-1464-1584
Ti, Mint
Text and Data Mining valid from 2019-01-08
Version of Record valid from 2019-01-08
Article History
Received: 23 August 2018
Accepted: 5 December 2018
First Online: 8 January 2019